Cullinan Therapeutics, Inc. (CGEM) SEC Filings — 2025
12 SEC filings for Cullinan Therapeutics, Inc. (CGEM) in 2025.
Filings
- Cullinan Therapeutics Files 8-K — 8-K · Dec 8, 2025
- Cullinan Therapeutics, Inc. 8-K Filing — 8-K · Nov 21, 2025
- Cullinan's R&D Surge Drives 41% Net Loss Increase — 10-Q · Nov 6, 2025
- Cullinan Therapeutics Files 8-K — 8-K · Nov 3, 2025
- Cullinan Therapeutics Files 8-K — 8-K · Sep 4, 2025
- Cullinan Posts Q2 Net Loss of $55.3M Amid R&D Push — 10-Q · Aug 7, 2025
- Cullinan Therapeutics Files 8-K on Security Holder Votes — 8-K · Jun 12, 2025
- Cullinan Therapeutics Files 8-K for Material Agreement — 8-K · Jun 4, 2025
- Cullinan Therapeutics Files Q1 2025 10-Q — 10-Q · May 8, 2025
- Cullinan Therapeutics Files DEF 14A on Executive Compensation — DEF 14A · Apr 25, 2025
- Cullinan Therapeutics Files 2024 10-K — 10-K · Feb 27, 2025
- Cullinan Therapeutics Files 8-K — 8-K · Jan 29, 2025